Regulations.gov document
Attachment 3 Copy of proposed draft labeling for Hydromorphone HCl extended-release…
Supporting & Related Material · FDA-2017-P-6219 · posted Oct 24, 2017
Key facts
| Document ID | FDA-2017-P-6219-0005 |
|---|---|
| Title | Attachment 3 Copy of proposed draft labeling for Hydromorphone HCl extended-release tablets, 24 mg re Citizen Petition from Axinn, Veltrop & Harkrider LLP |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2017-P-6219 |
| Posted | Oct 24, 2017 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: